Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction cisplatin + vinorelbine followed by CHART versus CHART alone in inoperable non-small cell lung cancer
ISRCTN63027630Phase 3Completed
- Sponsor
- Medical Research Council
- Start
- May 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of cisplatin and vinorelbine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Medical Research Council. Primary endpoint: Overall survival. Started May 2005; status: completed.
02
Drugs
cisplatinvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on ISRCTN63027630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN63027630.